Australian Chlamydia Treatment Study (ACTS) (ID 889253) - BioProject

Format

Choose Destination

Accession: PRJEB12313 ID: 889253

Australian Chlamydia Treatment Study (ACTS)

Women attending sexual health centres in Australia were recruited and followed for 56 days post-treatment with 1g azithromycin. More...

Accession	PRJEB12313
Scope	Monoisolate
Submission	Registration date: 11-Oct-2022 UNIVERSITY OF TECHNOLOGY, SYDNEY
Locus Tag Prefix	BN3599

Project Data:

Parameter	Value
Data volume, Gbases	120
Data volume, Mbytes	43250

Supplemental Content

Australian Chlamydia Treatment Study (ACTS)
Australian Chlamydia Treatment Study (ACTS)
A cohort study of azithromycin treatment failure in women with Chlamydia infections.

BioProject
Chain AX, 60S ribosomal protein L17-A
Chain AX, 60S ribosomal protein L17-A
gi|2463611609|pdb|8BQX|AX

Protein

Your browsing activity is empty.

Activity recording is turned off.